FINWIRES · TerminalLIVE
FINWIRES

ESAB Faces Softer Q1 on Middle East Pause With 2026 Outlook Intact, Oppenheimer Says

-- ESAB (ESAB) is expected to report Q1 results "modestly below prior expectations" due to a temporary pause in Middle East orders and some war-related cost and supply-chain headwinds, Oppenheimer said Monday in a report.

ESAB makes welding equipment and gas-control systems used across industrial, infrastructure and energy markets. Oppenheimer said broader 2026 demand trends remain generally in line and noted it is encouraged by ESAB's reaffirmed guidance ranges, which call for total sales growth of 6% to 9%, EBITDA of $575 million to $595 million and adjusted earnings per share of $5.70 to $5.90

Oppenheimer trimmed its EPS estimates to $5.80 from $5.87 in 2026 and to $6.50 from $6.55 in 2027, while maintaining an upside bias given ESAB's positioning in high-growth markets and its runway for mergers and acquisitions.

Q1 results are due May 7.

Oppenheimer maintained its outperform rating on ESAB stock with a $140 price target.

Price: $103.76, Change: $+1.37, Percent Change: +1.34%

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605